These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 19379446)
1. Convective renal replacement therapies for acute renal failure and end-stage renal disease. Huang Z; Li B; Zhang W; Gao D; Kraus MA; Clark WR Hemodial Int; 2004 Oct; 8(4):386-93. PubMed ID: 19379446 [TBL] [Abstract][Full Text] [Related]
2. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence. Thomas G; Jaber BL Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830 [TBL] [Abstract][Full Text] [Related]
3. Convective dialysis therapies, current status and perspective. Ledebo I Ther Apher Dial; 2005 Jun; 9(3):223-7. PubMed ID: 15966994 [TBL] [Abstract][Full Text] [Related]
4. Renal replacement therapy in acute renal failure: solute removal mechanisms and dose quantification. Clark WR; Ronco C Kidney Int Suppl; 1998 May; 66():S133-7. PubMed ID: 9573590 [TBL] [Abstract][Full Text] [Related]
6. [Pro convection: are convective therapies like hemodiafiltration and hemofiltration the future of extracorporeal blood purification?]. Bolasco PG G Ital Nefrol; 2008; 25(4):389-95. PubMed ID: 18663685 [TBL] [Abstract][Full Text] [Related]
7. Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms. Clark WR; Gao D J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S41-7. PubMed ID: 11792761 [TBL] [Abstract][Full Text] [Related]
8. Middle-molecule clearance in CRRT: in vitro convection, diffusion and dialyzer area. Messer J; Mulcahy B; Fissell WH ASAIO J; 2009; 55(3):224-6. PubMed ID: 19282753 [TBL] [Abstract][Full Text] [Related]
9. [Renal replacement therapy by hemodialysis: an overview]. Jacobs C Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513 [TBL] [Abstract][Full Text] [Related]
11. Are convective methods superior to diffusive dialytic methods? Cala S Acta Med Croatica; 2000; 54(1):21-5. PubMed ID: 10914437 [TBL] [Abstract][Full Text] [Related]
12. Selection of modality of renal replacement therapy. Abi Antoun T; Palevsky PM Semin Dial; 2009; 22(2):108-13. PubMed ID: 19426412 [TBL] [Abstract][Full Text] [Related]
13. On-line hemodiafiltration. Gold standard or top therapy? Passlick-Deetjen J; Pohlmeier R Contrib Nephrol; 2002; (137):201-11. PubMed ID: 12101956 [TBL] [Abstract][Full Text] [Related]
14. Renal replacement therapy in the intensive care unit. Bellomo R; Ronco C Crit Care Resusc; 1999 Mar; 1(1):13-24. PubMed ID: 16599859 [TBL] [Abstract][Full Text] [Related]
15. Recent clinical advances in the management of critically ill patients with acute renal failure. Clark WR; Letteri JJ; Uchino S; Bellomo R; Ronco C Blood Purif; 2006; 24(5-6):487-98. PubMed ID: 17003528 [TBL] [Abstract][Full Text] [Related]
16. Rationale and experience with short daily hemofiltration. Jaber BL; Zimmerman DL Semin Dial; 2004; 17(2):146-50. PubMed ID: 15043618 [TBL] [Abstract][Full Text] [Related]
17. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill]. Morabito S; Pistolesi V; Cibelli L; Pierucci A G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959 [TBL] [Abstract][Full Text] [Related]